{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:03:49Z","timestamp":1768345429236,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf03349742","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T15:18:11Z","timestamp":1397143091000},"page":"436-440","source":"Crossref","is-referenced-by-count":57,"title":["Prolactinoma in 53 men: Clinical characteristics and modes of treatment (male prolactinoma)"],"prefix":"10.1007","volume":"18","author":[{"given":"Meir","family":"Berezin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"BF03349742_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.0954-6820.1985.tb01642.x","volume":"217","author":"AL Hulting","year":"1985","unstructured":"Hulting A.L., Muhr C., Lundberg P.O., Werner S. Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment. Acta Med. Scand. 217: 101, 1985.","journal-title":"Acta Med. Scand."},{"key":"BF03349742_CR2","first-page":"1782","volume":"11","author":"T Eversmann","year":"1981","unstructured":"Eversmann T., Eichinger R., Fahlbusch R., Rjosk H.K., von Werder K. Die Hyperprolaktinemie beim Mann: Klinik and Therapie. Schweiz. Med. Wochenschr. 11: 1782, 1981.","journal-title":"Schweiz. Med. Wochenschr."},{"issue":"Suppl.","key":"BF03349742_CR3","first-page":"915","volume":"6","author":"HG Friesen","year":"1977","unstructured":"Friesen H.G., Tolis G. The use of bromocriptine in the galactorrhea-amen-orrhoea syndromes: the Canadian co-operative study. Clin. Endocrinol (Oxf.) 6(Suppl.): 915, 1977","journal-title":"Clin. Endocrinol (Oxf.)"},{"key":"BF03349742_CR4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0002-9343(77)90866-X","volume":"62","author":"F Gomez","year":"1977","unstructured":"Gomez F., Reyes F.I., Faiman C. Nonpuerperal galactorrhea and hyperprolactinemia: Clinical findings, endocrine features and therapeutic responses in 56 cases. Am. J. Med. 62: 648, 1977.","journal-title":"Am. J. Med."},{"key":"BF03349742_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM197703172961103","volume":"296","author":"DL Kleinberg","year":"1977","unstructured":"Kleinberg D.L., Noel G.L, Frantz A.G. Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N. Engl. J. Med. 296: 589, 1977.","journal-title":"N. Engl. J. Med."},{"key":"BF03349742_CR6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJM197610212951711","volume":"295","author":"HS Jacobs","year":"1976","unstructured":"Jacobs H.S. Prolactin and amenorrhea. N. Engl. J. Med. 295: 954, 1976.","journal-title":"N. Engl. J. Med."},{"key":"BF03349742_CR7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM197810192991602","volume":"299","author":"JN Carter","year":"1978","unstructured":"Carter J.N., Tyson J.E., Tolis G., van Vliet S., Faiman C., Friesen H.G. Prolactin-secreting tumors and hypogonadism in 22 men. N.Engl. J. Med. 299: 847, 1978.","journal-title":"N.Engl. J. Med."},{"key":"BF03349742_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(82)91094-7","volume":"2","author":"RF Spark","year":"1982","unstructured":"Spark R.F., Wills C.A., O\u2019Reilly G., Ransil B.J., Bergland R. Hyperprolactinemia in males with and without pituitary macroadenomas. Lancet 2: 129, 1982.","journal-title":"Lancet"},{"key":"BF03349742_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(82)90975-8","volume":"1","author":"RWG Prescott","year":"1982","unstructured":"Prescott R.W.G., Johnston D.G., Kendall-Taylor P. et al. Hyperprolactinemia in men-response to bromocriptine therapy. Lancet 1: 245, 1982.","journal-title":"Lancet"},{"key":"BF03349742_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7326\/0003-4819-105-2-238","volume":"105","author":"S Melmed","year":"1986","unstructured":"Melmed S., Braunstein G.D. Chang R.J., Becker D.P. Pituitary tumors secreting growth hormone and prolactin. Ann. Intern. Med. 105: 238, 1986.","journal-title":"Ann. Intern. Med."},{"key":"BF03349742_CR11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0344-0338(11)80161-5","volume":"187","author":"RV Llyod","year":"1991","unstructured":"Llyod R.V., Jin L., Fields K., Kulig E. Effects of estrogens on pituitary cell and prolactinoma tumor growth. Pathol. Res. Pract. 187: 632, 1991.","journal-title":"Pathol. Res. Pract."},{"key":"BF03349742_CR12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3171\/jns.1988.68.4.0554","volume":"68","author":"DL Barrow","year":"1988","unstructured":"Barrow D.L., Mizuno J., Tidall G.T. Management of prolactinomas associated with very high serum prolactin levels. J. Neurosurg. 68: 554, 1988.","journal-title":"J. Neurosurg."},{"key":"BF03349742_CR13","first-page":"877","volume":"21","author":"ME Molitch","year":"1992","unstructured":"Molitch M.E. Pathologic hyperprolactinemia in Endocrinology and Metabolism. Clin. North Am. 21: 877, 1992.","journal-title":"Clin. North Am."},{"key":"BF03349742_CR14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.288.6424.1105","volume":"288","author":"A Grossman","year":"1984","unstructured":"Grossman A., Cohen B.L., Charlesworth M., Plowman P.N., Rees Lesley H., Wass J.A.H., Jones A.E., Besser G.M. Treatment of prolactinomas with megavoltage radiotherapy. Br.Med. J. 288: 1105, 1984.","journal-title":"Br.Med. J."},{"key":"BF03349742_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1978.tb03574.x","volume":"9","author":"M Nagulsparen","year":"1978","unstructured":"Nagulsparen M., Ang V., Jenkins J.S. Bromocriptine treatment of males with pituitary tumors, hyperprolactinemia, and hypogonadism. Clin. Endocrinol. 9: 73, 1978.","journal-title":"Clin. Endocrinol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03349742\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:46:49Z","timestamp":1558507609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03349742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF03349742"],"URL":"https:\/\/doi.org\/10.1007\/bf03349742","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}